160 related articles for article (PubMed ID: 31257946)
41. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
42. Low powder mass filling of dry powder inhalation formulations.
Eskandar F; Lejeune M; Edge S
Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180
[TBL] [Abstract][Full Text] [Related]
43. Novel dry powder inhalation system based on dispersion of lyophilisates.
Claus S; Schoenbrodt T; Weiler C; Friess W
Eur J Pharm Sci; 2011 May; 43(1-2):32-40. PubMed ID: 21440061
[TBL] [Abstract][Full Text] [Related]
44. Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation.
Cuvelier B; Eloy P; Loira-Pastoriza C; Ucakar B; Sanogo AA; Dupont-Gillain C; Vanbever R
Int J Pharm; 2015 Nov; 495(2):981-90. PubMed ID: 26456267
[TBL] [Abstract][Full Text] [Related]
45. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
[TBL] [Abstract][Full Text] [Related]
46. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
47. [Study on preparation and pharmacodynamics of insulin-loaded polyester microparticles].
Ma LM; Zhang Q; Li YZ; Gu ZW
Yao Xue Xue Bao; 2000 Nov; 35(11):850-3. PubMed ID: 11218865
[TBL] [Abstract][Full Text] [Related]
48. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
49. Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery.
Wilson EM; Luft JC; DeSimone JM
Pharm Res; 2018 Aug; 35(10):195. PubMed ID: 30141117
[TBL] [Abstract][Full Text] [Related]
50. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
[TBL] [Abstract][Full Text] [Related]
51. Technosphere inhaled insulin (Afrezza).
Rendell M
Drugs Today (Barc); 2014 Dec; 50(12):813-27. PubMed ID: 25588086
[TBL] [Abstract][Full Text] [Related]
52. Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery.
Ni R; Zhao J; Liu Q; Liang Z; Muenster U; Mao S
Eur J Pharm Sci; 2017 Mar; 99():137-146. PubMed ID: 27988327
[TBL] [Abstract][Full Text] [Related]
53. Supercritical Fluid-Assisted Porous Microspheres for Efficient Delivery of Insulin and Inhalation Therapy of Diabetes.
Lin XF; Kankala RK; Tang N; Xu PY; Hao LZ; Yang DY; Wang SB; Zhang YS; Chen AZ
Adv Healthc Mater; 2019 Jun; 8(12):e1800910. PubMed ID: 30284409
[TBL] [Abstract][Full Text] [Related]
54. Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying.
Ceschan NE; Bucalá V; Ramírez-Rigo MV; Smyth HD
Eur J Pharm Biopharm; 2016 Dec; 109():72-80. PubMed ID: 27697595
[TBL] [Abstract][Full Text] [Related]
55. Dexamethasone palmitate large porous particles: A controlled release formulation for lung delivery of corticosteroids.
N'Guessan A; Fattal E; Chapron D; Gueutin C; Koffi A; Tsapis N
Eur J Pharm Sci; 2018 Feb; 113():185-192. PubMed ID: 28890202
[TBL] [Abstract][Full Text] [Related]
56. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
Mönckedieck M; Kamplade J; Fakner P; Urbanetz NA; Walzel P; Steckel H; Scherließ R
Int J Pharm; 2017 May; 524(1-2):351-363. PubMed ID: 28347847
[TBL] [Abstract][Full Text] [Related]
57. Biodegradable solid lipid nanoparticle flocculates for pulmonary delivery of insulin.
Yang X; Liu Y; Liu C; Zhang N
J Biomed Nanotechnol; 2012 Oct; 8(5):834-42. PubMed ID: 22888755
[TBL] [Abstract][Full Text] [Related]
58. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
[TBL] [Abstract][Full Text] [Related]
59. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.
Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA
Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447
[TBL] [Abstract][Full Text] [Related]
60. Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment.
Teymouri Rad R; Dadashzadeh S; Vatanara A; Alavi S; Ghasemian E; Mortazavi SA
Eur J Pharm Sci; 2019 May; 133():275-286. PubMed ID: 30953751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
